Zalsenertant tetraxetan
Zalsenertant tetraxetan (IPN-01087) is a DOTA-conjugated antagonist of the neurohypophyseal hormone receptor subtype 1 (NTSR1) . Zalsenertant tetraxetan is labeled with the radioactive isotope Lu-177 (177Lu), which can be used for molecular imaging to identify potential responders. Zalsenertant tetraxetan can be used in the radiotherapy research of solid tumors[1].
Product Specifications
CAS Number
[1613265-38-5]
Product Name Alternative
IPN-01087
UNSPSC
12352005
Target
Neurokinin Receptor
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
O=C(CN1CCN(CCN(CCN(CC1)CC(O)=O)CC(N(CCCN(CCCN(C)C(C2=CC=C(N3N=C(C(NC4(C5CC6CC(CC4C6)C5)C(O)=O)=O)C=C3C7=C(OC)C=CC=C7OC)C(C(C)C)=C2)=O)C)C)=O)CC(O)=O)O
Molecular Formula
C58H84N10O13
Molecular Weight
1129.35
References & Citations
[1]Ringwood UK. Ronny Living with neuroendocrine tumors.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Browse additional items from our catalog
Glo1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)